Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 24,106 | 23,471 | 17,694 | 19,826 | 14,674 |
| Cost of Goods | 21,858 | 21,843 | 16,567 | 18,211 | 15,460 |
| Gross Profit | 2,247 | 1,628 | 1,127 | 1,614 | -786 |
| Operating Expenses | 953 | 543 | 398 | 315 | 393 |
| Operating Income | 1,294 | 1,085 | 729 | 1,299 | -1,179 |
| Other Income | -136 | 204 | 199 | -7,934 | 197 |
| Pre-tax Income | 1,158 | 1,289 | 928 | -6,635 | -983 |
| Income Tax | 409 | 407 | 199 | 452 | -328 |
| Net Income Continuous | 749 | 882 | 729 | -7,088 | -655 |
| Minority Interests | N/A | N/A | N/A | -1 | 131 |
| Net Income | $749 | $882 | $729 | $-7,088 | $-655 |
| EPS Basic Total Ops | 0.08 | 0.09 | 0.07 | -0.74 | -0.07 |
| EPS Basic Continuous Ops | 0.08 | 0.09 | 0.07 | -0.74 | -0.07 |
| EPS Diluted Total Ops | 0.08 | 0.09 | 0.07 | -0.74 | -0.07 |
| EPS Diluted Continuous Ops | 0.08 | 0.09 | 0.07 | -0.74 | -0.07 |
| EBITDA(a) | $2,251 | $1,637 | $1,127 | $1,614 | $-786 |